Significant research news last week included French biotech Abivax releasing positive new Phase III data on obefazimod for ...

South Korea-based Celltrion on Friday announced that the US Food and Drug Administration (FDA) has approved Eydenzelt ...

UK pharma major AstraZeneca on Friday announced an agreement with US President Donald Trump’s administration to lower the ...

US pharma major Bristol Myers Squibb has entered into a definitive agreement to acquire Orbital Therapeutics, a privately ...

UK pharma major AstraZeneca announced that it will now invest $4.5 billion in its new manufacturing facility in Virginia, a ...

Spanish plasma-based medicines producer Grifols announced that Yimmugo, an innovative intravenous immunoglobulin (IVIg) ...

US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...

German pharma major Bayer’s gene therapy subsidiary AskBio today announced initial safety data from the first cohort of ...

India-headquartered Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral ...

Expedition Therapeutics has closed a $165 million series A financing, just two months after acquiring global rights outside ...

US venture firm Ascenta Capital has closed its inaugural fund at $325 million, marking a significant milestone two years ...

Swedish oncology specialist Xspray Pharma has received a complete response letter (CRL) from the US Food and Drug ...